
Ryman Healthcare Ltd
NZX:RYM

Intrinsic Value
The intrinsic value of one
RYM
stock under the Base Case scenario is
5.66
NZD.
Compared to the current market price of 2.37 NZD,
Ryman Healthcare Ltd
is
Undervalued by 58%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Ryman Healthcare Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Ryman Healthcare Ltd
Balance Sheet Decomposition
Ryman Healthcare Ltd
Current Assets | 199m |
Cash & Short-Term Investments | 22.6m |
Receivables | 174.5m |
Other Current Assets | 1.9m |
Non-Current Assets | 12.6B |
Long-Term Investments | 10.8B |
PP&E | 1.5B |
Intangibles | 77.5m |
Other Non-Current Assets | 225.5m |
Free Cash Flow Analysis
Ryman Healthcare Ltd
NZD | |
Free Cash Flow | NZD |
Earnings Waterfall
Ryman Healthcare Ltd
Revenue
|
722.5m
NZD
|
Operating Expenses
|
-753.8m
NZD
|
Operating Income
|
-31.2m
NZD
|
Other Expenses
|
-139.9m
NZD
|
Net Income
|
-171.1m
NZD
|
RYM Profitability Score
Profitability Due Diligence
Ryman Healthcare Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Score
Ryman Healthcare Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
RYM Solvency Score
Solvency Due Diligence
Ryman Healthcare Ltd's solvency score is 19/100. The higher the solvency score, the more solvent the company is.

Score
Ryman Healthcare Ltd's solvency score is 19/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RYM Price Targets Summary
Ryman Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
RYM
is 3.75 NZD
with a low forecast of 3.27 NZD and a high forecast of 4.94 NZD.
Dividends
Current shareholder yield for RYM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
RYM
stock under the Base Case scenario is
5.66
NZD.
Compared to the current market price of 2.37 NZD,
Ryman Healthcare Ltd
is
Undervalued by 58%.